Earnings · China A-shares
Shanxi C&Y Pharmaceutical Group Co., Ltd. Class A (300254) earnings
Shanxi C&Y Pharmaceutical Group Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -11.27% year on year, -32.29% excluding one-off items. Wave Radar's earnings-quality score is 90 of 100 (Sound). The stock moved -4.04% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -11.27%
- Excl. one-offs YoY
- -32.29%
- Net profit QoQ
- +1545.37%
- Result
- Neutral
- Quality score
- 90
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +2.60% | — |
| 3 days | -4.04% | — |
| 7 days | +0.65% | — |
| 14 days | -5.73% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 2 of 7 reports (average -0.27%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥19.81M | -11.27% | -32.29% | -11.97% | 0.08 | 4.81% | -4.04% | — | — |
| 2026 interim report | 2026-08-25 | ¥4.29M | +1025.28% | +206.26% | -5.66% | 0.02 | 1.14% | -3.56% | -6.29% | -0.26% |
| 2026 Q1 report | 2026-04-28 | ¥3.34M | -67.83% | -38.85% | -4.37% | 0.01 | 1.08% | +12.03% | -22.74% | -22.12% |
| 2025 annual report | 2026-04-28 | ¥24.85M | -41.10% | +25.87% | +2.86% | 0.10 | 8.91% | +12.03% | -22.74% | -22.12% |
| 2025 Q3 report | 2025-10-30 | ¥22.33M | -49.43% | -35.73% | +0.44% | 0.09 | 8.10% | -0.81% | -7.53% | -2.79% |
| 2025 interim report | 2025-08-26 | ¥380.87K | -98.86% | — | -7.01% | 0.00 | 0.14% | -6.14% | -11.70% | -13.38% |
| 2025 Q1 report | 2025-04-19 | ¥10.39M | -43.17% | -82.48% | -4.09% | 0.04 | 3.66% | +6.41% | +17.25% | +14.30% |
| 2024 annual report | 2025-04-15 | ¥42.19M | +67.45% | +232.73% | +5.92% | 0.17 | 7.24% | -5.76% | +7.07% | +4.05% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.